Page 1 - EndoProxy2012_final

Endo
100 Endo Boulevard
Chadds Ford, PA 19317
610.558.9800
endo.com
endo | AMS Endo Pharmaceuticals HealthTronics Qualitest
April 27, 2012
Dear Fellow Endo Pharmaceuticals Holdings Inc. Stockholder:
It is my pleasure to invite you to the Annual Meeting of Stockholders of Endo Pharmaceuticals Holdings Inc. (the Company),
which will be held on May 23, 2012 at 10:00 a.m., local time, at our corporate headquarters located at 100 Endo Boulevard,
Chadds Ford, Pennsylvania 19317.
At the meeting, we will be electing nine members of our Board of Directors, voting to ratify the selection of Deloitte & Tou-
che LLP as our independent registered public accounting firm, conducting an advisory vote on the compensation of our
named executive officers and voting to approve the amendment and restatement of the Company’s Amended and Restated
Certificate of Incorporation to change the name of the Company to Endo Health Solutions Inc. In addition to these formal
items of business, we will report on our Company’s performance.
We look forward to seeing you at the Annual Meeting should you be able to attend. If you do plan to attend, please bring the
enclosed Stockholder Admission Ticket with you.
Your vote is important. Whether you plan to attend the meeting or not, we encourage you to read this Proxy State-
ment and vote your shares. Please sign, date and return the enclosed proxy card as soon as possible in the postage-
paid envelope provided. You may revoke your proxy at any time before it is exercised as explained in this Proxy
Statement.
Thank you for your continued interest in Endo.
Very truly yours,
DAVID P. HOLVECK
President and Chief Executive Officer
April 27, 2012
Tis Proxy Statement and the accompanying proxy card are being mailed to stockholders on or about April 27, 2012.